Fundraising FoxIkarian Capital
Venture capitalDallas · Series A–Late Stage
Also known as IKARIAN CAPITAL, LLC
Find your way into Ikarian Capital
Sign up to find every way you can get introduced to Ikarian Capital
- Your email: who you already know at Ikarian Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ikarian Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Ikarian Capital invests in biotech companies advancing drug discovery and development, led by a team with scientific and biotech-specific finance expertise. It selects companies pursuing cutting-edge science with sound business fundamentals across the spectrum of early- to late-stage clinical trials, remaining agnostic to indication, market cap, and geography. The firm deploys transformational, long-term capital to support emerging companies as they progress through the clinic. It emphasizes a selective, contrarian approach backed by a proprietary process aligned with the team's core expertise, and is committed to building an enduring business with strong values and high ethical standards.
Source: firm website, verified Sep 29, 2026.
What they invest in
from 3 of 4 portfolio companiesBiotech ×2Healthtech ×2Enterprise Software ×1Fintech ×1PropTech ×1
HQs:United States×3New Zealand×1
Investments · 4 tracked
founders shown can be your intro pathBy year:2026 · 22021 · 13 dated
Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases.
BiotechHealthtechRedwood City, US
Judith Shizuru(Director)Herb Cross(Executive Officer)inJeet Mahal(Executive Officer, Director)inPatrick Crutcher(Director)Svetlana Lucas(Director)Wenru Song(Executive Officer)
Co-investorsAvego BioScience CapitalQiming Venture Partners USATSVCAbingworth
Jasper is a commercial real estate fund management firm that deploys and manages capital for institutional investors into industrial, logistics, and other asset classes across Australia and New Zealand.
Enterprise SoftwareFintechPropTechAuckland, NZ
Mark Campbell(CEO and Executive Director)in
Co-investorsBlackstoneArc AngelsFantail VenturesIcehouse VenturesBessemer Venture PartnersCoatue Management+5 more
Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases.
BiotechHealthtechCambridge, US
Wenru Song(Founder)in
Co-investorsForesite CapitalQuan CapitalVivo Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsJasper TherapeuticsNASDAQ: JSPR
Frequently asked questions
- What stage does Ikarian Capital invest at?
- Ikarian Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Ikarian Capital focus on?
- Ikarian Capital focuses on Biotech.
- Where is Ikarian Capital located?
- Ikarian Capital is headquartered in Dallas, US.
Similar investors
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.